2Foweraker JE, Laughton CR, Brown DF, et al. Comparison of methods to test antibiotic combinations against heterogeneous populations of multiresistant Pseudomonas aeruginosa from patients with acute infective exacerbations in cystic fi brosis[J]. Antimicrob Agents Chemother, 2009, 53 (11): 4809-4815.
3Falagas ME, Koletsi PK, Bliziotis IA. The diversity of deft nitions of multidrug-resistant (MDR) and pandrug resistant (PDR) Acinetobacter baumannii and Pseudomonas aerugino sa[J]. J Med Microbiol,2006,55(Pt 12): 1519-1629.
4Aaron SD, Ferris W, Henry DA, et al. Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia [J]. Am J Respir Crit Care Med,2000,161(4 Pt 1): 1206-1212.
5Zavascki AP, Goldani LZ, Li J, et at. Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review [J]. J Antimicrob Chemother, 2007,60(6): 1206-1215.
6Oie S, Uematsu T, Sawa A, et al. In vitro effects of combinations of antipseudomonal agents against seven strains of multidrug resistant Pseudomonas aeruginosa [J]. J Antimicrob Chemother,2003, 52(6): 911-914.
7Montanari MP, Piccoli L, Mingoia M, et al. Synergistic po tential of ceftazidime plus amikacin or levofloxacin against Pseudomonas aeruginosa as determined using a checkerboard and a disk diffusion technique[J]. Diagn Microbiol Infect Dis, 2005,53(2): 157-160.
8Burgess DS, Hall RG, Hardin TC. In vitro evaluation of the activity of two doses of levofloxacin alone and in combination with other agents against Pseudomonas aeruginosa [J]. Diagn Microbiol Infect Dis,2003, 46(2): 131-137.
9Landman D, Bratu S, Alam M, et al. Citywide emergence of Pseudomonas aeruginosa strains with reduced susceptibility to polymyxin B[J]. J Antimicrob Chemother, 2005,55 (6) : 954-957.
10Souli M, Galani I, Giamarellou H. Emergence of extensively drug resistant and pandrug resistant Gram negative bacilli in Europe[J]. Euro Surveill,2008,13(47) pii: 19045.
